NovaBridge Biosciences

NBP Healthcare Biotechnology

EPS
−123.3%
Free cash flow
+34.3%

Quarter to June 2026, against a year earlier

0.90 0.01 −1.10%
Market cap
$105.3M
P/E
0.0×
Fwd P/E
−2.5×
Dividend yield
—
F-score
n/a
Altman Z
−3.80
Beneish M
n/a
Dividend safety
n/a
Jun '26 Sep '25 Jun '25 Mar '25 Older periods
P/E ratio
— — — —

+8 more quarters

EV/Sales
— — — —
EV/FCF
— — — —
Current Ratio
7.64 14.47 22.82 22.35
Net Debt/EBITDA
0.00 0.00 23.28 32.02
Debt/Equity
0.00 0.00 0.00 0.00
Free Cash Flow Yield
— — — —
Free Cash Flow per Share
0.00 0.00 (0.10) 0.00
Book value per Share
0.00 0.00 2.41 2.52
Free Cash Flow
(32.93) 1.84 (7.79) —
EV/EBIT
— — — —
Other line items

Show all line items

Columns are period end dates · fundamentals updated 26 Oct 2026